[{"Assets_0_Q3_USD":151362000.0,"CommonStockSharesOutstanding_0_Q3_shares":30769000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-39587000.0,"NetIncomeLoss_1_Q3_USD":-16486000.0,"NetIncomeLoss_3_Q3_USD":-56290000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":28616000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":76700000.0,"StockholdersEquity_0_Q3_USD":52085000.0,"Ticker":"NSTG","CIK":"1401708","name":"NANOSTRING TECHNOLOGIES INC","OfficialName":"NanoString Technologies Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"995164151.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]